LivaNova PLC (LIVN)

Market Cap	2.86B
Revenue (ttm)	1.19B
Net Income (ttm)	-31.77M
Shares Out	54.15M
EPS (ttm)	-0.60
PE Ratio	n/a
Forward PE	16.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	535,484
Open	54.46
Previous Close	54.48
Day's Range	52.75 - 54.46
52-Week Range	42.75 - 64.48
Beta	0.99
Analysts	Buy
Price Target	65.50 (+23.84%)
Earnings Date	Jul 31, 2024

About LIVN

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable p...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 10, 1993
• Employees: 2,900
• Stock Exchange: NASDAQ
• Ticker Symbol: LIVN

Analyst Forecast

According to 6 analysts, the average rating for LIVN stock is "Buy." The 12-month stock price forecast is $65.5, which is an increase of 23.84% from the latest price.

Price Target

$65.5

(23.84% upside)

Analyst Consensus: Buy